id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-0234-0029,FDA,FDA-2014-D-0234,Clinical Pharmacology Data To Support a Demonstration of Biosimilarity to a Reference Product; Guidance for Industry; Availability,Notice,Notice of Availability,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T14:18:33Z,2016-31511,0,0,090000648243d24e
FDA-2014-D-0234-0030,FDA,FDA-2014-D-0234,Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product Guidance for Industry,Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2024-11-12T06:15:55Z,,1,0,090000648243d98f